Aberrant splicing but not mutations of TSG101 in human breast cancer

Maxwell P. Lee, Andrew P Feinberg

Research output: Contribution to journalArticle

Abstract

The llp15 gene TSG1O1 was recently reported to undergo frequent large intragenic deletions in human breast cancer. Here we show that that is generally not the case, but the gene shows aberrant splicing, based on the following observations: identical products were observed in matching normal and fetal tissues; deleted eDNA sequence revealed canonical splicing donor and acceptor site sequences; and genomic Southern blots showed no intragenic deletions in all 72 tumors studied. Nevertheless, relaxation of RNA splicing fidelity may be an oncodevelopmental marker in cancer and may play a general role in other genes and tumors.

Original languageEnglish (US)
Pages (from-to)3131-3134
Number of pages4
JournalCancer Research
Volume57
Issue number15
StatePublished - 1997

Fingerprint

Breast Neoplasms
Mutation
Genes
RNA Splicing
Neoplasms
Southern Blotting
Fetus

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Aberrant splicing but not mutations of TSG101 in human breast cancer. / Lee, Maxwell P.; Feinberg, Andrew P.

In: Cancer Research, Vol. 57, No. 15, 1997, p. 3131-3134.

Research output: Contribution to journalArticle

@article{2814a4640b0d4f96af8815360097d1ec,
title = "Aberrant splicing but not mutations of TSG101 in human breast cancer",
abstract = "The llp15 gene TSG1O1 was recently reported to undergo frequent large intragenic deletions in human breast cancer. Here we show that that is generally not the case, but the gene shows aberrant splicing, based on the following observations: identical products were observed in matching normal and fetal tissues; deleted eDNA sequence revealed canonical splicing donor and acceptor site sequences; and genomic Southern blots showed no intragenic deletions in all 72 tumors studied. Nevertheless, relaxation of RNA splicing fidelity may be an oncodevelopmental marker in cancer and may play a general role in other genes and tumors.",
author = "Lee, {Maxwell P.} and Feinberg, {Andrew P}",
year = "1997",
language = "English (US)",
volume = "57",
pages = "3131--3134",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Aberrant splicing but not mutations of TSG101 in human breast cancer

AU - Lee, Maxwell P.

AU - Feinberg, Andrew P

PY - 1997

Y1 - 1997

N2 - The llp15 gene TSG1O1 was recently reported to undergo frequent large intragenic deletions in human breast cancer. Here we show that that is generally not the case, but the gene shows aberrant splicing, based on the following observations: identical products were observed in matching normal and fetal tissues; deleted eDNA sequence revealed canonical splicing donor and acceptor site sequences; and genomic Southern blots showed no intragenic deletions in all 72 tumors studied. Nevertheless, relaxation of RNA splicing fidelity may be an oncodevelopmental marker in cancer and may play a general role in other genes and tumors.

AB - The llp15 gene TSG1O1 was recently reported to undergo frequent large intragenic deletions in human breast cancer. Here we show that that is generally not the case, but the gene shows aberrant splicing, based on the following observations: identical products were observed in matching normal and fetal tissues; deleted eDNA sequence revealed canonical splicing donor and acceptor site sequences; and genomic Southern blots showed no intragenic deletions in all 72 tumors studied. Nevertheless, relaxation of RNA splicing fidelity may be an oncodevelopmental marker in cancer and may play a general role in other genes and tumors.

UR - http://www.scopus.com/inward/record.url?scp=0030854026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030854026&partnerID=8YFLogxK

M3 - Article

C2 - 9242438

AN - SCOPUS:0030854026

VL - 57

SP - 3131

EP - 3134

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -